StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

AstraZeneca's pe ratio was 50.1× on Oct 19, 2026, against 73.2× a year earlier. Over the last 5 years it ranged from 46.9× to 138.8×, with a median of 71.0×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202650.1×−31.6
2025Dec 31, 202581.7×+12.9
2024Dec 31, 202468.8×−58.9
2023Dec 29, 2023127.7×+78.8
2017Jan 31, 201748.8×−0.2
2016Dec 30, 201649.0×–

More AstraZeneca figures

See a number that looks wrong?